-+ 0.00%
-+ 0.00%
-+ 0.00%

Liminatus Pharma Appoints Eric Sunghee Kang as Chief Corporate Strategist

PUBT·11/18/2026 21:17:19
Listen to the news
Liminatus Pharma Appoints Eric Sunghee Kang as Chief Corporate Strategist
  • Liminatus Pharma appointed Eric Sunghee Kang chief corporate strategist on Nov. 16, 2026, effective immediately.
  • Kang will report to CEO Chris Kim, overseeing corporate finance, capital markets strategy and new business initiatives.
  • He has led Seoul-based Quantinum Investment since 2022, focusing on cross-border capital markets transactions.
  • His background includes serving as head of strategy and finance at a Nasdaq-listed company in 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-129711), on November 18, 2026, and is solely responsible for the information contained therein.